1. Antiproliferative effects of CC-8062 and CC-8075 in pancreatic cancer cells.
- Author
-
Mouratidis PX, Colston KW, Bartlett JB, Muller GW, Man HW, Stirling D, and Dalgleish AG
- Subjects
- Alitretinoin, Apoptosis drug effects, Cell Line, Tumor, Dose-Response Relationship, Drug, Humans, Imidazoles pharmacology, Pancreatic Neoplasms enzymology, Phosphorylation, Protein Kinase Inhibitors pharmacology, Pyridines pharmacology, Signal Transduction drug effects, Tretinoin pharmacology, p38 Mitogen-Activated Protein Kinases antagonists & inhibitors, p38 Mitogen-Activated Protein Kinases metabolism, Antineoplastic Agents pharmacology, Cell Proliferation drug effects, Cyclic Nucleotide Phosphodiesterases, Type 4 pharmacology, Pancreatic Neoplasms pathology, Phosphodiesterase 4 Inhibitors, Phosphodiesterase Inhibitors pharmacology
- Abstract
Objectives: Pancreatic cancer is one of the leading causes of cancer related deaths in the western world. It is also resistant to most chemotherapeutic modalities. Phosphodiesterase-4 inhibitors (PDE4is) have found applications in the treatment of respiratory diseases. The aim of this study is to investigate the cytotoxic effect of 2 novel PDE4is, the CC-8075 and CC-8062 compounds in pancreatic cancer cells., Methods: Cell proliferation was measured using the sulforhodamine B protein dye. Induction of apoptosis was detected using enzyme-linked immunosorbent assay. Regulation of proteins and posttranslational modifications were determined using immunoblotting., Results: Treatment of pancreatic cancer cells with CC-8075 and CC-8062 reduces their proliferation and increases apoptosis that is caspase dependent in T3M4 cells. Furthermore, PDE4is increase phosphorylation of p38MAPK, mitogen-activated protein kinase (MAPK) kinase 3/6,MAPKYactivated protein kinase 2, Atf2, and Hsp27. The use of thep38MAPK-specific inhibitors SB202190 and SB203580 results in a modest reduction in PDE4i-induced apoptosis in T3M4 cells. Also, retinoids enhance apoptosis induced by CC-8075 and CC-8062 in GER cells., Conclusions: These results highlight the antiproliferative effects of the phosphodiesterase inhibitors CC-8075 and CC-8062 in pancreatic cancer cells and suggest that activation of p38MAPK signaling pathway may be associated with this process.
- Published
- 2009
- Full Text
- View/download PDF